Abstract
e15053 Background: There is no standard treatment of 2L for mGC. Irinotecan has been shown to increase overall survival (OS) in this setting. FOLFIRI is an active and well-tolerated regimen which h...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
